6883

SHH:688399

Jiangsu Bioperfectus Technologies Co., Ltd.

  • Stock

CNY

Last Close

64.71

30/04 07:00

Market Cap

4.01B

Beta: 1.04

Volume Today

285.28K

Avg: 492.31K

PE Ratio

113.16

PFCF: −706.40

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
16.67M
-
15.98M
4.16%
16.50M
3.26%
90.92M
451.04%
206.60M
127.24%
243.30M
17.76%
average payables
6.26M
-
8.41M
34.25%
26.93M
220.31%
91.92M
241.34%
246.05M
167.67%
392.99M
59.72%
average receivables
16.28M
-
21.07M
29.40%
34.68M
64.58%
110.45M
218.49%
278.10M
151.78%
511.63M
83.97%
book value per share
6.33
-
5.92
6.48%
7.36
24.44%
22.55
206.22%
28.39
25.93%
43.28
52.43%
64.45
48.91%
capex per share
-0.56
-
-0.67
18.56%
-2.24
236.71%
-2.34
4.15%
-2.30
1.76%
-5.18
125.71%
-5.98
15.49%
capex to depreciation
-3.78
-
-3.02
20.04%
-7.12
135.59%
-6.09
14.41%
-6.09
0.02%
-7.35
20.57%
-3.73
49.19%
capex to operating cash flow
-1.01
-
-0.48
53.01%
-1.15
141.81%
-0.99
13.85%
-0.14
85.49%
-0.31
114.27%
-0.18
42.06%
capex to revenue
-0.17
-
-0.16
9.68%
-0.43
173.52%
-0.37
14.42%
-0.08
78.88%
-0.11
38.26%
-0.06
40.74%
cash per share
0.31
-
0.49
58.51%
4.82
875.87%
18.32
280.11%
24.51
33.80%
32.60
33.02%
47.88
46.86%
days of inventory on hand
237.69
-
201.74
15.13%
121.04
40.00%
131.49
8.63%
152.48
15.96%
104.27
31.62%
39.56
62.06%
days payables outstanding
76.95
-
84.78
10.18%
80.09
5.53%
308.88
285.64%
130.39
57.79%
146.96
12.71%
72.53
50.65%
days sales outstanding
50.41
-
28.71
43.04%
43.37
51.04%
53.02
22.26%
37.55
29.18%
48.50
29.17%
42.60
12.16%
debt to assets
0.02
-
0.05
113.57%
0.02
54.78%
debt to equity
0.03
-
0.06
115.33%
0.03
57.57%
dividend yield
0.00
-
0.01
697.53%
0.02
-
0.04
158.90%
0.11
184.40%
earnings yield
0.00
-
0.02
361.90%
0.03
49.48%
0.03
20.93%
0.07
127.48%
0.15
103.72%
0.36
140.08%
enterprise value
2.17B
-
2.39B
10.12%
2.20B
7.89%
2.37B
7.68%
10.19B
329.35%
6.94B
31.92%
3.45B
50.20%
enterprise value over ebitda
178.21
-
43.58
75.55%
27.87
36.04%
21.92
21.36%
10.56
51.82%
4.89
53.70%
1.34
72.69%
ev to operating cash flow
98.34
-
38.84
60.50%
25.68
33.90%
22.23
13.41%
10.89
51.04%
7.04
35.35%
1.76
75.02%
ev to sales
16.82
-
12.77
24.07%
9.55
25.23%
8.22
13.98%
5.86
28.73%
2.44
58.28%
0.62
74.46%
free cash flow per share
-0.01
-
0.73
10,563.22%
-0.29
139.99%
0.02
107.11%
13.67
65,435.81%
11.64
14.88%
27.53
136.64%
free cash flow yield
-0.00
-
0.01
10,563.22%
-0.01
139.99%
0.00
106.74%
0.07
19,628.21%
0.08
19.08%
0.31
270.96%
graham net net
-0.02
-
-0.20
1,181.24%
3.82
2,048.84%
16.27
325.77%
17.73
8.95%
23.14
30.50%
39.18
69.33%
graham number
5.47
-
11.36
107.84%
15.50
36.39%
30.64
97.66%
94.50
208.48%
140.81
49.00%
212.63
51.01%
income quality
2.64
-
1.44
45.37%
1.34
6.85%
1.27
5.24%
1.14
10.38%
0.83
27.67%
1.07
30.15%
intangibles to total assets
0.01
-
0.01
23.39%
0.06
742.82%
0.02
65.82%
0.01
47.29%
0.01
34.35%
0.01
26.88%
0
100%
interest coverage
-803.00
-
-1.11K
38.31%
-39.80
96.42%
-24.12
39.40%
11.59K
48,135.13%
352.09
96.96%
403.34
14.56%
interest debt per share
-0.00
-
-0.00
295.77%
-0.04
3,942.77%
-0.09
108.05%
0.86
1,082.46%
2.87
235.59%
1.86
35.14%
inventory turnover
1.54
-
1.81
17.82%
3.02
66.68%
2.78
7.95%
2.39
13.77%
3.50
46.23%
9.23
163.57%
invested capital
0.03
-
0.06
115.33%
0.03
57.57%
market cap
2.18B
-
2.41B
10.49%
2.42B
0.07%
2.62B
8.51%
11.28B
330.15%
8.06B
28.53%
5.14B
36.19%
net current asset value
209.52M
-
200.43M
4.34%
182.18M
9.11%
756.88M
315.47%
1.17B
54.14%
1.58B
35.08%
2.60B
64.74%
net debt to ebitda
-1.02
-
-0.40
61.11%
-2.68
578.14%
-2.30
14.38%
-1.13
50.88%
-0.79
29.84%
-0.65
17.57%
net income per share
0.21
-
0.97
361.90%
1.45
49.48%
1.85
27.59%
13.98
655.68%
20.36
45.64%
31.18
53.14%
operating cash flow per share
0.55
-
1.40
152.32%
1.95
39.25%
2.36
20.90%
15.96
577.25%
16.82
5.34%
33.52
99.31%
payables turnover
4.74
-
4.31
9.24%
4.56
5.85%
1.18
74.07%
2.80
136.89%
2.48
11.28%
5.03
102.63%
receivables turnover
7.24
-
12.71
75.56%
8.42
33.79%
6.88
18.21%
9.72
41.21%
7.53
22.58%
8.57
13.84%
research and ddevelopement to revenue
0.11
-
0.11
3.15%
0.11
0.04%
0.13
16.74%
0.04
68.97%
0.04
9.33%
0.03
10.62%
return on tangible assets
0.03
-
0.14
368.72%
0.17
24.64%
0.07
56.99%
0.36
390.67%
0.34
5.62%
0.38
9.38%
revenue per share
3.24
-
4.26
31.26%
5.24
23.10%
6.38
21.71%
29.68
365.21%
48.44
63.24%
94.41
94.89%
roe
0.03
-
0.16
393.91%
0.20
20.13%
0.08
58.33%
0.49
500.10%
0.47
4.46%
0.48
2.84%
roic
0.02
-
0.16
697.79%
0.20
21.06%
0.08
58.37%
0.48
481.71%
0.44
7.79%
0.47
6.87%
sales general and administrative to revenue
0.28
-
0.10
63.04%
0.04
65.94%
0.03
17.90%
0.02
13.35%
0.02
34.97%
0.02
38.78%
shareholders equity per share
6.33
-
5.92
6.48%
7.36
24.44%
22.55
206.22%
28.39
25.93%
43.28
52.43%
64.45
48.91%
stock based compensation to revenue
tangible asset value
249.03M
-
257.89M
3.56%
298.47M
15.74%
995.22M
233.44%
1.64B
64.58%
2.51B
53.22%
3.75B
49.45%
tangible book value per share
6.25
-
5.86
6.27%
6.78
15.66%
21.98
224.18%
27.94
27.10%
42.82
53.27%
63.98
49.41%
working capital
212.60M
-
202.68M
4.66%
198.24M
2.19%
796.22M
301.65%
1.26B
57.92%
1.68B
33.87%
2.78B
64.95%

All numbers in CNY (except ratios and percentages)